Bio-Rad Laboratories Inc (BIO)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	337,796	361,149	364,846	398,121	482,616	481,834	543,992	545,882	500,336	568,059	520,855	447,815	421,326	294,920	242,780	247,428	229,661	-56,598	-77,783	-90,381
Revenue (ttm)	US$ in thousands	2,637,846	2,686,946	2,731,337	2,741,910	2,774,598	2,777,098	2,856,467	2,894,713	2,922,702	2,979,702	2,876,119	2,701,076	2,540,271	2,374,971	2,288,622	2,311,881	2,292,289	2,284,689	2,267,881	2,271,474
Operating profit margin		12.81%	13.44%	13.36%	14.52%	17.39%	17.35%	19.04%	18.86%	17.12%	19.06%	18.11%	16.58%	16.59%	12.42%	10.61%	10.70%	10.02%	-2.48%	-3.43%	-3.98%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $337,796K ÷ $2,637,846K
= 12.81%

Bio-Rad Laboratories Inc.'s operating profit margin has shown some fluctuations over the past eight quarters. The trend indicates a gradual decline from Q4 2022 to Q1 2023, with the margin decreasing from 17.22% to 14.43%. However, there was a slight uptick in Q2 2023 before decreasing again in Q3 2023 and Q4 2023. Overall, the company has maintained a relatively healthy operating profit margin above 12% throughout the period, indicating efficient cost management and profitability in its operations. The downward trend in recent quarters may suggest potential challenges or increasing costs that impacted the company's profitability, warranting further investigation to assess the sustainability of its margins.